Cargando…
Short-Acting β(2)-Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Thoracic Society
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605194/ https://www.ncbi.nlm.nih.gov/pubmed/32687403 http://dx.doi.org/10.1164/rccm.202006-2297LE |
| _version_ | 1783604264426274816 |
|---|---|
| author | Nannini, Luis J. |
| author_facet | Nannini, Luis J. |
| author_sort | Nannini, Luis J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7605194 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American Thoracic Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76051942020-11-02 Short-Acting β(2)-Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6 Nannini, Luis J. Am J Respir Crit Care Med Correspondence American Thoracic Society 2020-11-01 2020-11-01 /pmc/articles/PMC7605194/ /pubmed/32687403 http://dx.doi.org/10.1164/rccm.202006-2297LE Text en Copyright © 2020 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org). |
| spellingShingle | Correspondence Nannini, Luis J. Short-Acting β(2)-Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6 |
| title | Short-Acting β(2)-Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6 |
| title_full | Short-Acting β(2)-Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6 |
| title_fullStr | Short-Acting β(2)-Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6 |
| title_full_unstemmed | Short-Acting β(2)-Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6 |
| title_short | Short-Acting β(2)-Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6 |
| title_sort | short-acting β(2)-agonist use could be a confounding factor for interpreting increased il-6 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605194/ https://www.ncbi.nlm.nih.gov/pubmed/32687403 http://dx.doi.org/10.1164/rccm.202006-2297LE |
| work_keys_str_mv | AT nanniniluisj shortactingb2agonistusecouldbeaconfoundingfactorforinterpretingincreasedil6 |